PDEX
What one share of Pro-Dex holds
Surgical and Medical Instruments and Apparatus
“we,” “our,” or “us”) specializes in the design, development and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used primarily in the orthopedic, thoracic, and craniomaxillofacial markets.
Pro-Dex’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $23.38 |
|---|---|
| Profit | $4.12 |
| Capex (buildings and equipment) | $0.15 |
| Free cash flow | $2.04 |
| Cash and investments | $2.98 |
| Debt | $5.48 |
| Book value | $14.95 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2017 | $5.38 | $1.25 | $0.15 | $0.64 | — | $3.41 |
| 2018 | $5.17 | $0.37 | $0.21 | $0.50 | — | $3.99 |
| 2019 | $6.32 | $0.96 | $0.32 | $0.45 | — | $4.21 |
| 2020 | $8.54 | $1.50 | $0.13 | $1.09 | — | $5.23 |
| 2021 | $9.66 | $1.57 | $0.45 | −$0.98 | — | $5.80 |
| 2022 | $11.17 | $1.21 | $0.44 | −$0.66 | — | $7.07 |
| 2023 | $12.67 | $1.95 | — | $1.50 | — | $8.91 |
| 2024 | $15.08 | $0.60 | — | $1.74 | — | $9.18 |
| 2025 | $19.81 | $2.67 | $0.37 | −$0.87 | — | $11.23 |
| 2026 | $23.38 | $4.12 | $0.15 | $2.04 | — | $14.95 |